Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
308.35
-5.6 (-1.78%)
BSENSE

Dec 05

BSE+NSE Vol: 1.09 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
SMS Pharma.
Senores Pharma.
Aarti Drugs
RPG LifeScience.
IOL Chemicals
Dishman Carbogen
Unichem Labs.
Advanced Enzyme
Indoco Remedies
Gufic BioScience
Hikal
Why is Advanced Enzyme Technologies Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -0.73% of over the last 5 years
2
With ROE of 9.9, it has a Very Expensive valuation with a 2.4 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -17.87%, its profits have fallen by -0.7%
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -17.87% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Advanced Enzyme for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Advanced Enzyme
-18.19%
-0.51
34.88%
Sensex
4.86%
0.41
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.30%
EBIT Growth (5y)
-0.73%
EBIT to Interest (avg)
69.28
Debt to EBITDA (avg)
0.19
Net Debt to Equity (avg)
-0.38
Sales to Capital Employed (avg)
0.46
Tax Ratio
28.52%
Dividend Payout Ratio
10.24%
Pledged Shares
0
Institutional Holding
31.82%
ROCE (avg)
20.60%
ROE (avg)
10.67%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
24
Industry P/E
40
Price to Book Value
2.37
EV to EBIT
16.51
EV to EBITDA
13.57
EV to Capital Employed
3.23
EV to Sales
4.17
PEG Ratio
NA
Dividend Yield
1.65%
ROCE (Latest)
19.55%
ROE (Latest)
9.93%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company
OPERATING CF(Y)

Highest at Rs 142.50 Cr

NET SALES(Q)

At Rs 184.53 cr has Grown at 26.30%

PBDIT(Q)

Highest at Rs 60.06 cr.

PBT LESS OI(Q)

Highest at Rs 49.26 cr.

PAT(Q)

Highest at Rs 43.33 cr.

EPS(Q)

Highest at Rs 3.87

-2What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 76.42 cr

Loading Valuation Snapshot...
Here's what is working for Advanced Enzyme
Operating Cash Flow - Annually
Highest at Rs 142.50 Cr and Grown
each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 49.26 cr has Grown at 51.15%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
At Rs 184.53 cr has Grown at 26.30%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 60.06 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 49.26 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 43.33 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 43.33 cr has Grown at 32.0%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 3.87
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Advanced Enzyme
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 76.42 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Non Operating Income - Quarterly
Highest at Rs 10.28 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income